TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Supraclavicular skin temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C-terminal telopeptide levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Bone and connective tissue outcomes
Primary endpoint: Serum 25(OH)D restoration to optimal level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 10-point visual disturbance score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NEI VFQ-25 improved general vision
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: NEI VFQ-25 improved mental health
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: femoral FMD%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Predicting lung cancer within 1 year
Endpoint domain: Mortality/survival
Primary endpoint: mean GSM-CCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: patient-reported outcomes (VAS scale)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Humeral head offset
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Center of rotation (COR) position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: contrast discrimination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: visual sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mPASI scores for arms and legs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: mean morning blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Forced expiratory volume in 1 s/forced vital capacity ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Asthma Control Test score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of patients with PIM/DDI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Content of cTnI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ratio of neutrophils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Increase in plasma PC-DHA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in plasma LPC-DHA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in total DHA in CSF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in depression, anxiety, and stress symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proteinuria at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: ABCG1-mediated CEC values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean decrease in grade of infraorbital dark circles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention rate of participants
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Absence of MBS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mRS score of 0-1 after three months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in deprivation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of adverse events of abnormal peripheral sensation (APS)
Endpoint domain: Adverse events/effects
Primary endpoint: relative hematoma expansion from baseline to follow‐up CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease of at least 10% in LVEF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall therapeutic success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival through 30 days post-study therapy
Endpoint domain: Mortality/survival
Primary endpoint: 30-day clinical cure score >4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of ECD loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to California's Healthy Beverages in Child Care Act
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of cardiovascular disease (CVD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sexual self-confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Societal costs
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: meibomian expression score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: OSDI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: tear osmolarity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: load to failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time to complete training modules
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pass rates for training modules
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of pendelluft
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Neurological function deficit score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Upper limb motor function (FMA and MAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Activities of daily living (MBI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: modified Rankin Scale (mRS) score 0-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QALYs gained per patient
Endpoint domain: Resource use
Primary endpoint: EPDS scores change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Femoral neck BMD percentage change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Total hip BMD percentage change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reduction in depression (PHQ-9)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in PDA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in VQ-Progress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Substance misuse
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: apparent volume of distribution (Vd/F)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of opioid tablets prescribed per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaccine effectiveness (VE) against any circulating influenza strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: improvement on periocular wrinkles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: improvement on skin textures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: maximum tolerated dose of rucaparib
Endpoint domain: Adverse events/effects
Primary endpoint: palliative care education needs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: time return to work
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: general ED pathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Helpfulness of dietary counseling for changing child's drinking habits
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of dietary counseling
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mortality associated with bleeding
Endpoint domain: Mortality/survival
Primary endpoint: Lumbar pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sciatic pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neecham score on postoperative day 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self‐rated change in ADHD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in target area hair count (TAHC) at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinic adoption rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Participant reach per clinic
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Failed initial attempt to discontinue NCPAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of posthepatectomy liver failure
Endpoint domain: Mortality/survival
Primary endpoint: Rate of morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: overall operative time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Implementation success of DCM
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Average core temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived temperature
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fear change during exposure therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Advanced tears
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in symptoms (OSDI and SANDE scores)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Severity Index (SI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dystonia Movement Evaluation (DME)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Atrial high rate episode >6 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Atrial high rate episode >6 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Atrial high rate episode >24 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: excellent functional outcome (modified Rankin Scale score 0–1)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: death within 3 months
Endpoint domain: Mortality/survival
Primary endpoint: ADAS-Cog14 improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of patients dying
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of patients with severe disability or coma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from AAR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete mucosal coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic toxicity grade 3 to 4
Endpoint domain: Adverse events/effects
Primary endpoint: GHS/QoL score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: changes in disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: days of admission
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: social relationships
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: ionized calcium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Missed HIV care appointments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: psychophysical and psychometric visual quality scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of primary open-angle glaucoma (POAG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Eye outcomes
Primary endpoint: lower leg pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: K-ODI scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: change in HI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: item-corrected source memory performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Time in target glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of hypoglycemic events per day
Endpoint domain: Adverse events/effects
Primary endpoint: Pulmonary vein AERPs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in DTSQs total score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in DDS2 score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: stain extent index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall stain index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fewer falls
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of myocardial infarction (MI) or cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of spontaneous major bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma levels of calcitonin gene‐related peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma levels of tryptase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma levels of histamine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mitochondrial energetic capacity (ΔATPmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional parameters of activity improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Strength and endurance of core muscle group
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posture control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balance ability and lower-limb motor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfaction with visual appearance of the treated leg
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Efficacy of low-dose atropine eyedrops in myopia control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerability of low-dose atropine eyedrops
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of low-dose atropine eyedrops
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in RMMA index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stroke or systemic arterial embolism (SAE)
Endpoint domain: Mortality/survival
Primary endpoint: stroke/SAE/cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: Local Recurrence (LRC)
Endpoint domain: Mortality/survival
Primary endpoint: composite of all-cause death, non-fatal reinfarction, or HF hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Preference for LAN new syringe
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Confidence the syringe will not be clogged
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 12-hour RER:FQ ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 12-hour fat balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: overall sexual pleasure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: force reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: repetitions fatigue index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: discomfort during resistance training
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: total opioid use in the first 24 hours after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ΔSkindex‐16 score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: DLQI score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ICDRG score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healthy purchases of dairy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Healthy purchases of grains
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Healthy purchases of fruits and vegetables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: MD difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSD difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exams duration
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: PaO2/FiO2 one hour after extubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: intraoperative respiratory mechanics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: maximum sensory level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability and validity of scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tooth color changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival free of liver transplantation
Endpoint domain: Mortality/survival
Primary endpoint: expression of nuclear factor of activated t‐cells 5 (NFAT5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sulfated heparan sulfate in skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial BDNF concentrations in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mRS score for good recovery
Endpoint domain: Mortality/survival
Primary endpoint: Mean contouring time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost advantage of MET over observation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost equivalence of ureteroscopy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Daily stone passage rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: %SRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cervical mucus quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Muscle insulin sensitivity (MISI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Well-being and quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Increase of β‐OHB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in 24 h systolic ABP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cumulative incidence of incisional hernias (IHs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of TB cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Risk of death associated with TB
Endpoint domain: Mortality/survival
Primary endpoint: △HT‐SDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: △height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: △IGF‐1 SDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in aggression ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in body mass index scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity and extent of adhesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of adhesion formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term outcomes of conservative and surgical management
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Non-availability of assistive technology (AT)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Financial constraints
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Quadriceps Peak Force (QPF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes